An Evaluation of Glucose Tolerance in Essential Hypertension

dc.contributor.authorTugrul, Armagan
dc.contributor.authorGuldiken, Sibel
dc.contributor.authorUgur-Altun, Betul
dc.contributor.authorArikan, Ender
dc.date.accessioned2024-06-12T10:59:25Z
dc.date.available2024-06-12T10:59:25Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: This study aimed to detemine the impaired glucose tolerance and diabetes prevalence in patients with essential hypertension (HT) and to compare the developed microvascular complications of these groups. Materials and Methods: An oral glucose tolerance test (OGTT) was performed on 338 essential hypertensive cases and glucose tolerances were classified according to ADA-2002 criteria. Results: Of the 338 cases, 32 people had diabetes (DM, 9.460/6), 78 people had glucose intolerance (IGT, 23.1%), and 228 people had only hypertension but not IGT and DM (67.4%). Both the mean ages of the DM group (56.9 +/- 6.7 years, p = 0.002) and IGT group (56.3 +/- 8.4 years, p = 0.003) were older than the mean age of the control group (51.1 +/- 6.4 years). The risk of IGT development was found to be four times greater in male cases than female cases when compared to the control group (p = 0.004, add ratio = 4.194). There were no significant differences in the body mass indexes (BMI's), hypertension durations, and microvascular complications between the groups. Conclusion: In conclusion, the risk of IGT and DM development in hypertensive cases increases with aging and longer hypertension duration. The risk of IGT development in hypertensive cases is four times more in males.en_US
dc.identifier.doi10.3349/ymj.2009.50.2.195
dc.identifier.endpage199en_US
dc.identifier.issn0513-5796
dc.identifier.issn1976-2437
dc.identifier.issue2en_US
dc.identifier.pmid19430550en_US
dc.identifier.scopus2-s2.0-66549129439en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage195en_US
dc.identifier.urihttps://doi.org/10.3349/ymj.2009.50.2.195
dc.identifier.urihttps://hdl.handle.net/20.500.14551/20438
dc.identifier.volume50en_US
dc.identifier.wosWOS:000265573900004en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherYonsei Univ Coll Medicineen_US
dc.relation.ispartofYonsei Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectGlucose Toleranceen_US
dc.subjectEpidemiologyen_US
dc.subjectHypertensionen_US
dc.subjectInsulin Resistanceen_US
dc.subjectAmerican-Diabetes-Associationen_US
dc.subjectImpaired Fasting Glucoseen_US
dc.subjectCardiovascular-Diseaseen_US
dc.subjectLife-Styleen_US
dc.subjectPrevalenceen_US
dc.subjectRisken_US
dc.subjectMortalityen_US
dc.subjectMellitusen_US
dc.subjectEpidemiologyen_US
dc.subjectMetabolismen_US
dc.titleAn Evaluation of Glucose Tolerance in Essential Hypertensionen_US
dc.typeArticleen_US

Dosyalar